Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Molecular psychiatry - 1 Mar 2011

Adkins D E, Aberg K, McClay J L, Bukszár J, Zhao Z, Jia P, Stroup T S, Perkins D, McEvoy J P, Lieberman J A, Sullivan P F, van den Oord E J C G

Abstract excerpt

Understanding individual differences in the susceptibility to metabolic side effects as a response to antipsychotic therapy is essential to optimize the treatment of schizophrenia. Here, we perform genomewide association studies (GWAS) to search for genetic variation affecting the susceptibility...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Blood Pressure
Share to Cholesterol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Rate

Share to Metabolic Diseases

Share to Pharmacogenetics

Share to Waist Circumference

Source

Open in PubMed Open full text

Identifiers

PMID: 20195266
DOI: 10.1038/mp.2010.14
PMCID: PMC2891163

Genes

MEIS2
ASTN2
FHOD3
SOX5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20195266-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.PMID 20195266Read ↗

Genetics of Common Antipsychotic-Induced Adverse EffectsSemantic proximity Read ↗

Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study.Semantic proximity Read ↗

Genetic Inference of On-target and Off-target Side-effects of Antipsychotic MedicationsSemantic proximity Read ↗

Genetic variants impacting metabolic outcomes among people on clozapine: a systematic review and meta-analysis.Semantic proximity Read ↗

Pharmacogenetic Study of Antipsychotic-Induced Lipid and BMI Changes in Chinese Schizophrenia Patients: A Genome-Wide Association StudySemantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced side effects.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced side effectsSemantic proximity Read ↗

Genome-wide association study identifies genetic loci associated with body mass index and high density lipoprotein-cholesterol levels during psychopharmacological treatment - a cross-sectional naturalistic study.Semantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

New findings in pharmacogenetics of schizophreniaSemantic proximity Read ↗

The pharmacogenetics of antipsychotic-induced adverse events.Semantic proximity Read ↗

Pharmacogenetics and outcome with antipsychotic drugsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.